시장보고서

상품코드

1555491

주산기 감염 시장 : 부문별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Perinatal Infections Market, By Infection, By Diagnosis, By Treatment, By Route of Administration, By End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 08월 | 리서치사: 구분자

AnalystView Market Insights | 페이지 정보: 영문 260 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

주산기 감염(Perinatal Infections) 시장 규모는 2023년에 41억 2,520만 달러였으며, 2024년부터 2032년까지 CAGR 6.00%로 추이하며 확대 될 것으로 예상

주산기 감염 시장-시장 역학

주산기 감염의 유병률 증가는 시장 성장 촉진

주산기 감염 세계 시장은 전 세계 출생 전 감염의 유병률 증가로 확대되고 있습니다. 이러한 감염은 모체와 유아 모두 심각한 위협에 노출되어 있으며 예방, 진단 및 치료 방법을 개선해야 할 필요성이 부각되었습니다. 임신 중이나 분만 중에는 언제든지 주산기 감염으로 인해 어머니의 건강과 태아의 건강이 위험에 처해 있습니다. 인간 면역결핍 바이러스(HIV), B형 간염, 매독, B군 연쇄상구균(GBS), 클라미디아는 유아에 영향을 미칠 수 있는 일반적인 질병입니다. 이러한 감염은 조산, 저체중아, 신생아 패혈증, 선천적 이상, 모체 이환 및 사망과 같은 심각한 결과를 초래할 수 있습니다. 또한, 주산기 감염의 발생 빈도는 많은 원인에 의해 상승하고 있습니다. 진단되지 않은 또는 치료되지 않은 감염은 출생 전 치료에 대한 접근이 불충분하거나 일부 지역에서는 건강 관리 자원이 부족하기 때문입니다. 출생 전 감염은 약제 중독, 무방비 성 행위, 여러 파트너의 존재 등 많은 고위험 행동으로 인해 발생할 수 있습니다. 예방과 교육 노력을 통해 이러한 습관을 다루는 것이 필수적입니다.

주산기 감염 시장-주요 인사이트

리서치 애널리스트 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 약 6.00%의 CAGR로 매년 성장할 것으로 추정됩니다.

감염별 세분화에 기초하여, 인간 면역결핍 바이러스 범주는 2023년에 가장 큰 시장 점유율을 나타냈습니다.

진단별 세분화에 근거하여, 2023년에는 모체 검사 범주가 주요 부문이였습니다.

치료별 세분화에 근거하여, 2023년에는 항생제 범주가 주요 감염이었습니다.

투여 경로의별 세분화에 기초하여, 2023년에는 비경구 투여 카테고리가 주요 부문이였습니다.

지역별로는 북미가 2023년 주요 수익원이었습니다.

주산기 감염 시장-세분화 분석 :

세계의 주산기 감염 시장은 감염, 진단, 치료, 투여 경로, 최종 사용자 및 지역에 따라 세분화됩니다.

시장은 진단에 따라 다음 범주로 나뉩니다. 모체 검사, 신생아 검사 등. 모체 검사 카테고리가 시장을 독점하고 있습니다. 배아와 태아는 거의 면역이 없으며, 그 결과 면역을 가지며 어머니에 의존합니다. 많은 질병은 태반을 통과한 후에 태아를 감염시킬 수 있습니다. 임산부가 가벼운 질병을 일으키는 박테리아가 발달중인 태아와 유아에게 심각한 위험을 초래할 수 있으므로 임산부는 종종 감염을 확인하기위한 진단 검사를 받습니다.

시장은 최종 사용자에 의해 다음 범주로 나뉩니다 : 병원, 재택치료, 전문 클리닉 등. 병원이 가장 안전한 출산 장소로 간주되기 때문에 병원 카테고리가 시장을 독점하고 있으며 예측 기간 동안에도 우위를 유지할 것으로 보입니다. National Academics의 보고서에 따르면 미국 여성의 98.4%가 병원에서 출산하고 있으며 이는 시장의 상당 부분을 차지하고 있다고 합니다. 그러나 병원이 아닌 집이나 전문 분만센터에서 출산을 선택하는 임산부가 늘고 있기 때문에 재택의료와 전문클리닉도 예측기간 중에 급증할 전망입니다.

주산기 감염 시장-지리적 통찰

지역적으로, 이 시장은 북미, 남미, 유럽, 아시아 태평양, 중동 및 아프리카의 각 지역으로 퍼져 있습니다. 이 지역은 비즈니스를 전개하는 국가에 따라 더 나뉩니다.

예측 기간 동안 북미는 주산기 감염 세계 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 조기 발견·조기 치료의 가치를 강조하기 위해, 이 지역의 헬스케어 업계는 출생 전 감염증에 대한 일반 시민의 인식을 높이기 위해 노력하고 있습니다. 북미에서는 스크리닝 프로그램, 예방접종 캠페인, 교육 이니셔티브 등 정부 시책이 빈번히 실시되어 주산기 감염 시장이 순조롭게 성장하고 있습니다.

게다가 주산기 감염 시장은 의료기술 혁신과 연구를 위한 다액 지출을 원동력으로 하여 아시아 태평양의 예측기간 동안 세계에서 가장 빠른 속도로 확대될 것으로 예측되고 있습니다. 아시아 태평양에서 실시한 연구 개발의 결과, 주산기 감염에 대한 선진적인 진단 도구와 치료 접근법이 등장하고 있습니다. 아시아 태평양의 주산기 감염 시장은 이 지역의 건강 관리 인프라의 확대와 모자의 건강 중시가 높아짐에 따라 계속 상승하고 있습니다.

주산기 감염 시장-경쟁 구도 :

Merck KGaA, Beckman Coulter Inc., BIOMERIEUX, Bio-Rad Laboratories, Inc., Danaher, Hologic Inc. 등 주산기 감염 시장의 주요 기업은 경쟁이 심한 환경에서 우위를 차지하기 때문에 제휴, M& A, 제품 혁신과 같은 전략적 노력에 주력하고 있습니다. 이러한 기업들은 진단의 혁신을 활용하고 제공하는 제품을 다양화함으로써 시장 점유율을 확대하고 고객과 의료 제공업체의 변화하는 수요를 충족시키고자 합니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아 태평양(APAC)
- 개요
- 아시아 태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
남미
- 개요
- 남미의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제13장 주요 벤더 분석-주산기 감염 산업

경쟁 대시보드
기업 프로파일
- Merck KgaA
- Beckman Coulter Inc.
- BIOMERIEUX
- Bio-Rad Laboratories, Inc
- Danaher
- Hologic Inc.
- Gilead Sciences, Inc.
- Emcure Pharmaceuticals Limited.
- Cipla Inc.
- Hetero
- Bausch Health Companies Inc.
- Johnson &Johnson Private Limited
- Mylan NV
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Novartis AG
- Sun Pharmaceutical Industries Ltd
- 기타

제14장 애널리스트의 전방위 전망

LYJ

REPORT HIGHLIGHT

Perinatal Infections Market size was valued at USD 4,125.2 Million in 2023, expanding at a CAGR of 6.00% from 2024 to 2032.

Infections that can spread from the mother to the child during pregnancy, labor, or the initial few hours after delivery are known as perinatal infections. Due to the limited ability of neonates, particularly those born preterm, to verbalize their symptoms, even slight deviations from the norm should be interpreted as an indication of bacterial disease. Pregnancy is a common time to see diseases such as listeria, bacterial vaginosis (BV), group B streptococcus (GBS), dermatitis, herpes, vaginal yeast infections, and the flu.

Perinatal Infections Market- Market Dynamics

Growing Prevalence of Perinatal Infections to Propel Market Growth

The global market for perinatal infections is expanding as a result of the rising prevalence of prenatal infections globally. The mother and the infant are both seriously threatened by these infections, which highlights the need for improved prevention, diagnostic, and treatment methods. Any time throughout pregnancy or during labor and delivery, a mother's health and the health of her unborn child are at danger due to perinatal infections. Human immunodeficiency virus (HIV), hepatitis B, syphilis, group B streptococcus (GBS), and chlamydia are common illnesses that can affect infants. Serious consequences include preterm birth, low birth weight, neonatal sepsis, congenital abnormalities, and mother morbidity and death can result from these infections. Furthermore, the frequency of perinatal infections is rising due to a number of causes. Undiagnosed or untreated infections are a result of inadequate access to prenatal care and scarce healthcare resources in some areas. Routine prenatal care visits are crucial to screen for and identify perinatal infections early on.Prenatal infections can result from a number of high-risk behaviors, including drug addiction, unprotected sexual activity, and having several partners. It is essential to address these habits through prevention and education initiatives.

Perinatal Infections Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.00% over the forecast period (2024-2032)

Based on infection segmentation, the human immunodeficiency virus category was predicted to show maximum market share in the year 2023

Based on diagnosis segmentation, the maternal test category was the leading segment in 2023

Based on treatment segmentation, the antibiotics category was the leading infection in 2023

Based on route of administration segmentation, the parenteral category was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Perinatal Infections Market- Segmentation Analysis:

The Global Perinatal Infections Market is segmented on the basis of Infection, Diagnosis, Treatment, Route of Administration, End User and Region.

The market is divided into three categories based on diagnosis: Maternal Test, Neonatal Test, and Others. The maternal test category dominates the market. The embryo and fetus have little to no immunity; as a result, they are immune and reliant on their mother. Many illnesses can infect the fetus after crossing the placenta. Pregnant women often undergo diagnostic testing to identify any infection since germs that cause mild illnesses in them might pose a serious risk to the developing fetus or infant.

The market is divided into the following categories based on end user: Hospitals, Homecare, Specialty Clinics, and Others. The hospitals category dominates the market and is likely to maintain its dominance during the forecast period, given that hospitals are thought to be the safest places to give birth. The National Academics reports that 98.4% of American women give birth in a hospital, which is a significant portion of the market. However, because more and more expectant mothers are choosing to give birth at home or in specialized birthing centers rather than in hospitals, homecare, and specialty clinics are also expected to see rapid expansion during the forecast period.

Perinatal Infections Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for Perinatal Infections. In order to emphasize the value of early identification and treatment, the healthcare industry in the area has worked hard to increase public awareness of prenatal infections. The market for perinatal infections is growing favorably as a result of government measures in North America, which frequently include screening programs, immunization campaigns, and educational initiatives.

In addition, the Perinatal Infections market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific driven by large expenditures for medical innovation and research. Advanced diagnostic tools and treatment approaches for perinatal infections have emerged as a result of research and development conducted in the Asia Pacific. The Asia Pacific market for perinatal infections is continuing to rise as a result of the region's expanding healthcare infrastructure and growing emphasis on mother and child health.

Perinatal Infections Market- Competitive Landscape:

Key companies in the perinatal infections market such as Merck KGaA, Beckman Coulter Inc., BIOMERIEUX, Bio-Rad Laboratories, Inc, Danaher, and Hologic Inc., among others, are concentrating on strategic efforts, including partnerships, mergers and acquisitions, and product innovations in order to obtain a competitive edge in a highly competitive landscape. These businesses hope to increase market share and satisfy customers' and healthcare providers' changing demands by capitalizing on diagnosis breakthroughs and diversifying their product offerings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERINATAL INFECTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Merck KgaA
Beckman Coulter Inc.
BIOMERIEUX
Bio-Rad Laboratories, Inc
Danaher
Hologic Inc.
Gilead Sciences, Inc.
Emcure Pharmaceuticals Limited.
Cipla Inc.
Hetero
Bausch Health Companies Inc.
Johnson & Johnson Private Limited
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi
Novartis AG
Sun Pharmaceutical Industries Ltd
Others

GLOBAL PERINATAL INFECTIONS MARKET, BY INFECTION- MARKET ANALYSIS, 2019 - 2032

Cytomegalovirus Infection
Enterovirus Infection
Genital Herpes
Gonorrhoea
Human Immunodeficiency Virus
Others

GLOBAL PERINATAL INFECTIONS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

Maternal Test
Neonatal Test
Others

GLOBAL PERINATAL INFECTIONS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

Antibiotics
Antiviral
Antiretroviral
Others

GLOBAL PERINATAL INFECTIONS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

Oral
Parenteral
Others

GLOBAL PERINATAL INFECTIONS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Homecare
Specialty Clinics
Others

GLOBAL PERINATAL INFECTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Perinatal Infections Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Perinatal Infections Market Snippet by Infection
- 2.1.2. Perinatal Infections Market Snippet by Diagnosis
- 2.1.3. Perinatal Infections Market Snippet by Treatment
- 2.1.4. Perinatal Infections Market Snippet by Route of Administration
- 2.1.5. Perinatal Infections Market Snippet by End User
- 2.1.6. Perinatal Infections Market Snippet by Country
- 2.1.7. Perinatal Infections Market Snippet by Region
2.2. Competitive Insights

3. Perinatal Infections Key Market Trends

3.1. Perinatal Infections Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Perinatal Infections Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Perinatal Infections Market Opportunities
3.4. Perinatal Infections Market Future Trends

4. Perinatal Infections Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Perinatal Infections Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Perinatal Infections Market Landscape

6.1. Perinatal Infections Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Perinatal Infections Market - By Infection

7.1. Overview
- 7.1.1. Segment Share Analysis, By Infection, 2023 & 2032 (%)
- 7.1.2. Cytomegalovirus Infection
- 7.1.3. Enterovirus Infection
- 7.1.4. Genital Herpes
- 7.1.5. Gonorrhoea
- 7.1.6. Human Immunodeficiency Virus
- 7.1.7. Others

8. Perinatal Infections Market - By Diagnosis

8.1. Overview
- 8.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
- 8.1.2. Maternal Test
- 8.1.3. Neonatal Test
- 8.1.4. Others

9. Perinatal Infections Market - By Treatment

9.1. Overview
- 9.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
- 9.1.2. Antibiotics
- 9.1.3. Antiviral
- 9.1.4. Antiretroviral
- 9.1.5. Others

10. Perinatal Infections Market - By Route of Administration

10.1. Overview
- 10.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
- 10.1.2. Oral
- 10.1.3. Parenteral
- 10.1.4. Others

11. Perinatal Infections Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 11.1.2. Hospitals
- 11.1.3. Homecare
- 11.1.4. Specialty Clinics
- 11.1.5. Others

12. Perinatal Infections Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Perinatal Infections Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Perinatal Infections Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.10. Italy
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. Italy Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.10.4. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.10.5. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.10.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.11. United Kingdom
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. United Kingdom Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.11.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.11.5. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.11.6. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.12. France
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. France Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.12.4. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.12.5. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.12.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.13. Russia
  - 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.2. Russia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.13.3. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.14. Netherlands
  - 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.2. Netherlands Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.14.3. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.14.4. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.14.5. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.2. Sweden Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.16. Poland
  - 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.2. Poland Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.16.3. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.17. Rest of Europe
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Rest of the Europe Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Perinatal Infections Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.9. India
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. India Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.9.4. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.9.5. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.9.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.10. China
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. China Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.10.4. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.10.5. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.10.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.14. Thailand
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Thailand Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.15. Indonesia
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Indonesia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Perinatal Infections Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Perinatal Infections Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Infection, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Perinatal Infections Industry

13.1. Competitive Dashboard
13.2. Company Profiles
- 13.2.1. Merck KgaA
- 13.2.2. Beckman Coulter Inc.
- 13.2.3. BIOMERIEUX
- 13.2.4. Bio-Rad Laboratories, Inc
- 13.2.5. Danaher
- 13.2.6. Hologic Inc.
- 13.2.7. Gilead Sciences, Inc.
- 13.2.8. Emcure Pharmaceuticals Limited.
- 13.2.9. Cipla Inc.
- 13.2.10. Hetero
- 13.2.11. Bausch Health Companies Inc.
- 13.2.12. Johnson & Johnson Private Limited
- 13.2.13. Mylan N.V.
- 13.2.14. Teva Pharmaceutical Industries Ltd.
- 13.2.15. Sanofi
- 13.2.16. Novartis AG
- 13.2.17. Sun Pharmaceutical Industries Ltd
- 13.2.18. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us